decitabine, cytarabine and arsenic trioxide
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for decitabine, cytarabine and arsenic trioxide, covering 2018-01-04 to 2018-01-04. Get the full timeline:
Most recent: Clinical Trial Update: Decitabine,Cytarabine and Arsenic Trioxide for Acute Myeloid Leukemia With p53 Mutations [Phase 2]